taqman® drug metabolism genotyping assays on ......2014/06/28 · 20 cyp2d6*17 g.1023c>t,...
TRANSCRIPT
![Page 1: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/1.jpg)
1 The world leader in serving science
TaqMan® Drug Metabolism Genotyping Assays on OpenArray® Plates June 28, 2014
![Page 2: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/2.jpg)
2
TaqMan® Drug Metabolism Genotyping Assays on OpenArray® Plates
Life Technologies® has pretested over 300 TaqMan® DME and SNP assays to highly studied, important DME and other gene variants on OpenArray® plates run on the QuantStudio™ 12K Flex Real-Time PCR System. Assays were tested on this system with 44 Coriell gDNAs (22 each African American and Caucasian samples, a subset of the TaqMan® DME Assay 90 sample validation panel) and most were also tested with synthetic plasmid constructs representing each genotype. You can download the PGx Common Markers file that contains a list of the most commonly requested assays from this set at: www.lifetechnologies.com/pgx The file includes common allele names, context sequences, and other useful annotations. This PowerPoint document contains screen shots of the test data for the most commonly requested PGx and clinical research target assays.
For Research Use Only. Not for use in diagnostic procedures. © 2014 Thermo Fisher Scientific. All rights reserved. All trademarks are the property of Thermo Fisher Scientific and its subsidiaries unless otherwise specified.
![Page 3: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/3.jpg)
3
CYP2D6*2A g.-1584C>G, rs1080985 C__32407252_30
Plasmid Samples
gDNA Samples
The CYP2D6*2 allele can be duplicated. Samples having 3 copies of CYP2D6 that are heterozygous for -1584C>G may run within or beside the heterozygous cluster.
![Page 4: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/4.jpg)
4
CYP2D6 g.2850C>T , rs16947 C__27102425_10
Plasmid Samples
2850C>T is a common SNP that is found in *2 and many other CYP2D6 star alleles. The *2 allele can be duplicated. Samples having 3 copies of CYP2D6 that are heterozygous for 2850C>T may run within or beside the heterozygous cluster.
gDNA Samples
![Page 5: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/5.jpg)
5
CYP2D6*2 g.4180G>C, rs1135840 C__27102414_10
Plasmid Samples
4180G>C is a common SNP that is found in *2 and many other CYP2D6 star alleles. The *2 allele can be duplicated. Samples having 3 copies of CYP2D6 that are heterozygous for 4180G>C may run within or beside the heterozygous cluster.
gDNA Samples
![Page 6: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/6.jpg)
6
CYP2D6*3 g.2549delA , rs35742686 C__32407232_50
Plasmid Samples
gDNA Samples
![Page 7: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/7.jpg)
7
CYP2D6*4 g.1846G>A , rs3892097 C__27102431_D0
Plasmid Samples
The CYP2D6 *4 allele can be duplicated. Samples having 3 copies of CYP2D6 that are heterozygous for 1846G>A may run within or beside the heterozygous cluster.
gDNA Samples
![Page 8: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/8.jpg)
8
CYP2D6*6 g.1707delT , rs5030655 C__32407243_20
Plasmid Samples
gDNA Samples
![Page 9: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/9.jpg)
9
CYP2D6*7 g.2935A>C, rs5030867 C__32388575_A0 – recommended *7 assay version
Plasmid Samples
C__32388575_A0 is an improved version of C__32388575_30 (slide 10). It has higher amplification signal due to reduction of NTC signal. We recommend using C__32388575_A0 to interrogate CYP2D6*7 g.2935A>C.
gDNA Samples
![Page 10: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/10.jpg)
10
CYP2D6*7 g.2935A>C , rs5030867 C__32388575_30 - improved assay version is available*
Plasmid Samples
The high NTC signal seen with C__32388575_30 is due to probe cleavage in the absence of template and amplification. It does not interfere with genotyping unless sample the amplification signal is low (e.g. due to low sample quantity). *We recommend using the improved assay design: C__32388575_A0 (slide 9). It has higher amplification signal due to reduction of NTC signal.
gDNA Samples
![Page 11: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/11.jpg)
11
CYP2D6*8 g.1758G>T, rs5030865 C_30634117C_K0 – recommended *8 assay version
C_30634117C_K0 reports the major (G) and one minor (T) allele (CYP2D6*8) of a triallelic SNP. C_30634117D_M0 reports the major (G) and other minor (A) allele (CYP2D6*14). Both assays should be independently run on samples and data analyzed as described in the PGx Experiments User Guide Chapter 5 section on triallelic and adjacent SNPs. C_30634117C_K0 is an improved version of C_30634117C_20 (slide 12), which has higher amplification signal due to a decrease in amplicon size.
gDNA Samples
![Page 12: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/12.jpg)
12
CYP2D6*8 g.1758G>T, rs5030865 C_30634117C_20 - improved assay version is available*
Plasmid Samples
C_30634117C_20 reports the major (G) and one minor (T) allele (CYP2D6*8) of a triallelic SNP. C_30634117D_30 reports the major (G) and other minor (A) allele (CYP2D6*14). Both assays should be independently run on samples and data analyzed as described in the PGx Experiments User Guide Chapter 5 section on triallelic and adjacent SNPs. * We recommend using the improved assay design: C_30634117C_K0 (slide 11). It has higher amplification signal due to a decrease in amplicon size.
gDNA Samples
![Page 13: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/13.jpg)
13
CYP2D6*9 g.2613_2615delAGA, rs28371720 C__32407229_60
Plasmid Samples
C__32407229_60 targets the CYP2D6*9 deletion variant, which can be denoted as g.2613_2615delAGA or g.2615_2617delAAG. The nucleotide deletion results in deletion of amino acid K281.
gDNA Samples
![Page 14: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/14.jpg)
14
CYP2D6*10 g.100C>T, rs1065852 C__11484460_40
Plasmid Samples Cycle 27
The CYP2D6*10 allele can be duplicated. Samples having 3 copies of CYP2D6 that are heterozygous for 100C>T may run within or beside the heterozygous cluster.
gDNA Samples
![Page 15: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/15.jpg)
15
CYP2D6*11 g.883G>C, rs5030863 C__30634118_A0
Plasmid Samples
C__30634118_A0 specifically amplifies CYP2D6 by targeting base differences between CYP2D6 and CYP2D7. Two of these base differences occur as SNPs in some CYP2D6*4 alleles, which thus cannot be amplified by the *11 assay. The CYP2D6*4 C__27102431_D0 assay should be run on the same samples for complete genotype analysis, as *4/*4 samples will not amplify with the *11 assay, and samples that run as *11/*11 may have *11/*11 or *4/*11 genotypes, which can be discerned by the *4 assay results.
gDNA Samples
![Page 16: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/16.jpg)
16
CYP2D6*12 g.124G>A , rs5030862 C__27531552_A0
Plasmid Samples
gDNA Samples
![Page 17: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/17.jpg)
17
CYP2D6*14 g.1758G>A, rs5030865 C_30634117D_M0 – recommended *14 assay version
C_30634117D_M0 reports the major (G) and one minor (A) allele (CYP2D6*14) of a triallelic SNP. C_30634117C_K0 reports the major (G) and other minor (T) allele (CYP2D6*8). Both assays should be independently run on samples and data analyzed as described in the PGx Experiments User Guide Chapter 5 section on triallelic and adjacent SNPs. C_30634117D_M0 is an improved version of C_30634117D_30 (slide 18), which has higher amplification signal due to a decrease in amplicon size.
gDNA Samples
![Page 18: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/18.jpg)
18
CYP2D6*14 g.1758G>A , rs5030865 C_30634117D_30 - improved assay version is available*
Plasmid Samples
C_30634117D_30 reports the major (G) and one minor (A) allele (CYP2D6*14) of a triallelic SNP. C_30634117C_20 reports the major (G) and other minor (T) allele (CYP2D6*8). Both assays should be independently run on samples and data analyzed as described in the PGx Experiments User Guide Chapter 5 section on triallelic and adjacent SNPs. * We recommend using the improved assay design: C_30634117D_M0 (slide 17). It has higher amplification signal due to a decrease in amplicon size.
gDNA Samples
![Page 19: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/19.jpg)
19
CYP2D6*15 g.137-138insT, rs72549357 C__32407245_40
Plasmid Samples
gDNA Samples
![Page 20: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/20.jpg)
20
CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version
The CYP2D6*17 allele can be duplicated. Samples having 3 copies of CYP2D6 that are heterozygous for 1023C>T may run within or beside the heterozygous cluster.
C___2222771_A0 is an improved version of C___2222771_40 (slide 21). It has been observed that C___2222771_40 cannot amplify a subset of *4 alleles and thus some *4/*17 samples will run as *17 homozygotes. E.g. In the experiment shown, samples NA17116 and NA17121 run as heterozygotes with C___2222771_A0 whereas they run as *17/*17 homozygotes with C___2222771_40.
gDNA Samples
![Page 21: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/21.jpg)
21
CYP2D6*17 g.1023C>T, rs28371706 C___2222771_40 - improved assay version is available*
Plasmid Samples
The CYP2D6*17 allele can be duplicated. Samples having 3 copies of CYP2D6 that are heterozygous for 1023C>T may run within or beside the heterozygous cluster.
It has been observed that C___2222771_40 cannot amplify a subset of *4 alleles and thus some *4/*17 samples will run as *17 homozygotes. E.g. In the experiment shown, samples NA17116 and NA17121 run as homozygotes with C___2222771_40 whereas they run as *17 heterozygotes with C___2222771_A0. *We recommend using the improved assay: C___2222771_A0 (slide 20) to interrogate CYP2D6*17 g.1023C>T.
gDNA Samples
![Page 22: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/22.jpg)
22
CYP2D6*29 g 3183G>A, rs59421388 C__34816113_20
Plasmid Samples
gDNA Samples
![Page 23: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/23.jpg)
23
CYP2D6*35 g.31G>A, rs769258 C__27102444_80
Plasmid Samples gDNA Sample Cycle 30
The CYP2D6*35 allele can be duplicated. Samples having 3 copies of CYP2D6 that are heterozygous for 31G>A may run within or beside the heterozygous cluster.
![Page 24: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/24.jpg)
24
CYP2D6*41 g.2988G>A (splicing defect) , rs28371725 C__34816116_20
Plasmid Samples
gDNA Samples
![Page 25: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/25.jpg)
25
CYP2C9*2 c.430C>T g.3608C>T , rs1799853 C__25625805_10
Plasmid Samples
gDNA Samples
![Page 26: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/26.jpg)
26
CYP2C9*3/*18 c.1075A>C, g.42614A>C, rs1057910 C__27104892_10
Plasmid Samples Cycle 32
The polymorphic CYP2C9*3/*18 c.1075A>C SNP is adjacent to the rare CYP2C9*4 c.1076T>C SNP that is detected by C__30634131_20 (slide 27). The *3/*18 and *4 SNP assays can be used to detect the 3 possible haplotypes described for this locus (alleles *3/*18 1076C and *4 1075C do not occur together in a haplotype). Analyze data as described in the PGx Experiments User Guide Chapter 5 section ‘TaqMan® DME genotyping assays to triallelic SNPs and adjacent SNP targets’.
gDNA Samples
![Page 27: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/27.jpg)
27
CYP2C9*4 c. 1076T>C, g.42615T>C, rs56165452 C__30634131_20
Note: the samples with higher signal are wild type for the adjacent *3/*18 c.1075A>C SNP, those in the lower split cluster are heterozygous for this SNP, and the sample that does not amplify is homozygous for the 1075C allele.
The rare CYP2C9*4 c.1076T>C SNP is adjacent to the polymorphic CYP2C9*3/*18 c.1075A>C SNP, which is detected by C__27104892_10 (slide 26). The *3/*18 and *4 SNP assays can be used to detect the 3 possible haplotypes described for this locus (alleles *3/*18 1076C and *4 1075C do not occur together in a haplotype). Analyze data as described in the PGx Experiments User Guide Chapter 5 section ‘TaqMan® DME genotyping assays to triallelic SNPs and adjacent SNP targets’.
gDNA Samples
![Page 28: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/28.jpg)
28
CYP2C9*5 c.1080C>G g.42619C>G , rs28371686 C__27859817_40
Plasmid Samples Cycle 27
gDNA Samples
![Page 29: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/29.jpg)
29
CYP2C9*6 c.818delA g.10601delA C__32287221_20
Plasmid Samples
gDNA Samples
![Page 30: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/30.jpg)
30
CYP2C9*8 c.449G>A g.3627G>A, rs7900194 C__25625804_10
Plasmid Samples
gDNA Samples
![Page 31: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/31.jpg)
31
CYP2C9*11 c.1003C>T g.42542C>T, rs28371685 C__30634132_70
Plasmid Samples
gDNA Samples
![Page 32: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/32.jpg)
32
CYP2C9*13 c.269T>C g.3276T>C, rs72558187 C__34816136_20
Plasmid Samples
gDNA Samples
![Page 33: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/33.jpg)
33
CYP2C9*27 c.449G>T g.3627G>T, rs7900194 C_25625804D_20
Plasmid Samples
gDNA Samples
![Page 34: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/34.jpg)
34
CYP2C19*2 g.19154G>A. c.681G>A (splicing defect) , rs4244285 C__25986767_70
Plasmid Samples
The polymorphic CYP2C19*2 c.681G>A SNP is adjacent to the rare CYP2C19*10 c.680C>T SNP that is detected by C__30634128_10 (slide 35). The *2 and *10 SNP assays can be used to detect the 3 possible haplotypes described for this locus (alleles *2 681A and *10 680T do not occur together in a haplotype). Analyze data as described in the PGx Experiments User Guide Chapter 5 section ‘TaqMan® DME genotyping assays to triallelic SNPs and adjacent SNP targets’.
gDNA Samples
![Page 35: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/35.jpg)
35
CYP2C19*10 c.680C>T g.19153C>T , rs6413438 C__30634128_10
The rare CYP2C19*10 c.680C>T SNP is adjacent to the polymorphic CYP2C19*2 c.681G>A SNP that is detected by C__25986767_70 (slide 34). The *2 and *10 SNP assays can be used to detect the 3 possible haplotypes described for this locus (alleles *2 681A and *10 680T do not occur together in a haplotype). Analyze data as described in the PGx Experiments User Guide Chapter 5 section ‘TaqMan® DME genotyping assays to triallelic SNPs and adjacent SNP targets’.
gDNA Samples
![Page 36: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/36.jpg)
36
CYP2C19*3 g.17948G>A , rs4986893 C__27861809_10
Plasmid Samples
gDNA Samples
![Page 37: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/37.jpg)
37
CYP2C19*4 c.1A>G g.1A>G, rs28399504 C__30634136_10
Plasmid Samples
gDNA Samples
![Page 38: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/38.jpg)
38
CYP2C19*5 g.90033C>T , rs56337013 C__27861810_10
Plasmid Samples
gDNA Samples
![Page 39: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/39.jpg)
39
CYP2C19*6 g.12748G>A, rs72552267 C__27531918_10
Plasmid Samples
gDNA Samples
![Page 40: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/40.jpg)
40
CYP2C19*7 g.19294T>A , rs72558186 C__30634127_10
Plasmid Samples
gDNA Samples
![Page 41: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/41.jpg)
41
CYP2C19*8 g.12711T>C , rs41291556 C__30634130_30
Plasmid Samples
gDNA Samples
![Page 42: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/42.jpg)
42
CYP2C19*9 c.431G>A g.12784G>A, rs28399507 C__25745302_30
Plasmid Samples
gDNA Samples
![Page 43: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/43.jpg)
43
CYP2C19*17 g.-806C>T, rs12248560 C____469857_10
Plasmid Samples
gDNA Samples
![Page 44: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/44.jpg)
44
CYP3A4*1B g.-392A>G, rs2740574 C___1837671_50
gDNA Samples
![Page 45: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/45.jpg)
45
CYP3A4*2 g.15713T>C , rs55785340 C__30634204_10
Plasmid Samples
gDNA Samples
![Page 46: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/46.jpg)
46
CYP3A4*3 c.1334T>C, rs4986910 C__27535825_20
Plasmid Samples
gDNA Samples
![Page 47: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/47.jpg)
47
CYP3A4*12 c.1117 C>T g.21896C>T, rs12721629 C__30634202_10
Plasmid Samples
gDNA Samples
![Page 48: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/48.jpg)
48
CYP3A4*16 c.554C>G g.15603C>G, rs12721627 C__30634207_10
Plasmid Samples
gDNA Samples
![Page 49: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/49.jpg)
49
CYP3A4*17 c.566 T>C g.15615T>C, rs4987161 C__27859822_10
Plasmid Samples
gDNA Samples
![Page 50: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/50.jpg)
50
CYP3A4*22 g.15389C>T, rs35599367 C__59013445_10
gDNA Samples
![Page 51: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/51.jpg)
51
CYP3A5*9 g.19386G>A, rs28383479 C__30633863_10
gDNA Samples
![Page 52: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/52.jpg)
52
CYP3A5*3B g.3705C>T, rs28383468 C__30633871_50
gDNA Samples
![Page 53: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/53.jpg)
53
CYP3A5*2 g.27289C>A, rs28365083 C__30633862_10
Plasmid Samples
gDNA Samples
![Page 54: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/54.jpg)
54
CYP3A5*3 g.6986A>G , rs776746 C__26201809_30
Plasmid Samples
gDNA Samples
![Page 55: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/55.jpg)
55
CYP3A5*3/*10 g.31611C>T, rs15524 C___8303531_40
Plasmid Samples
gDNA Samples
![Page 56: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/56.jpg)
56
CYP3A5*6 g.14690G>A, rs10264272 C__30203950_10
Plasmid Samples
gDNA Samples
![Page 57: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/57.jpg)
57
CYP3A5*7 g.27131_27132insT, rs41303343 C__32287188_10
Plasmid Samples
gDNA Samples
![Page 58: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/58.jpg)
58
CYP3A5*8 g.3699C>T, rs55817950 C__30633872_10
Plasmid Samples
gDNA Samples
![Page 59: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/59.jpg)
59
CYP1A2*1 g.-3860G>A, rs2069514 C__15859191_30
Plasmid Samples
gDNA Samples
![Page 60: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/60.jpg)
60
CYP1A2*1 g.-2467delT, rs35694136 C__60142977_10
Plasmid Samples
gDNA Samples
![Page 61: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/61.jpg)
61
CYP1A2*1K g.-729C>T, rs12720461 C__30634146_10
Plasmid Samples
gDNA Samples
![Page 62: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/62.jpg)
62
CYP1A2*1 g.-739T>G, rs2069526 C__16017734_10
Plasmid Samples
gDNA Samples
![Page 63: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/63.jpg)
63
CYP1A2*1F g.-163C>A, rs762551 C___8881221_40
Plasmid Samples Cycle 30
gDNA Samples
![Page 64: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/64.jpg)
64
CYP1A2*4 g.2499A>T, rs72547516 C__30634246_10
gDNA Samples
![Page 65: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/65.jpg)
65
CYP1A2*3 g.2116G>A, rs56276455 C__30634247_20
gDNA Samples
![Page 66: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/66.jpg)
66
CYP1A2*6 g.5090C>T, rs28399424 C__30634244_20
gDNA Samples
![Page 67: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/67.jpg)
67
CYP1A2*7 g.3533G>A, rs56107638 C__30634145_10
Plasmid Samples
gDNA Samples
![Page 68: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/68.jpg)
68
CYP1A2*8 g.5166G>A, rs72547517 C__72649745_10
gDNA Samples
![Page 69: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/69.jpg)
69
CYP1A2*11 g.558C>A, rs72547513 C__34816151_10
gDNA Samples
![Page 70: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/70.jpg)
70
CYP1A2*15 g.125C>G, rs72547511 C__72649743_10
gDNA Samples
![Page 71: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/71.jpg)
71
CYP1A2*16 g.2473G>A, rs72547515 C__72649744_20
gDNA Samples
![Page 72: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/72.jpg)
72
CYP1A2 g.5347T>C, rs2470890 C___1642455_10
Plasmid Samples
gDNA Samples
![Page 73: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/73.jpg)
73
CYP2B6 c.516G>T g.15631G>T, rs3745274 C___7817765_60
Plasmid Samples
gDNA Samples
![Page 74: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/74.jpg)
74
CYP2B6*5 c.1459C>T, g.25505C>T, rs3211371 C__30634242_40
Plasmid Samples
gDNA Samples
![Page 75: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/75.jpg)
75
CYP2B6*10 c.64C>T g.64C>T, rs8192709 C___2818162_20
Plasmid Samples Cycle 30
gDNA Samples
![Page 76: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/76.jpg)
76
CYP2B6*16/*18 c.983T>C g.21011T>C, rs28399499 C__60732328_20
Plasmid Samples
gDNA Samples
![Page 77: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/77.jpg)
77
CYP2B6*22 g.-82T>C, rs34223104 C__27830964_10
Plasmid Samples
gDNA Samples
![Page 78: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/78.jpg)
78
CYP2C8*2 c.805A>T g.11054A>T, rs11572103 C__30634034_10
Plasmid Samples
gDNA Samples
![Page 79: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/79.jpg)
79
CYP2C8*3 c.1196A>G g.30411A>G, rs10509681 C__25625782_20
Plasmid Samples
gDNA Samples
![Page 80: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/80.jpg)
80
CYP2C8*4 c.792C>G g.11041C>G, rs1058930 C__25761568_20
Plasmid Samples
gDNA Samples
![Page 81: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/81.jpg)
81
COMT c.322G>A or c.472G>A, rs4680 C__25746809_50
Plasmid Samples
gDNA Samples
![Page 82: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/82.jpg)
82
DRD2*A1 32806C>T Taq1A, rs1800497 C___7486676_10
gDNA Samples
![Page 83: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/83.jpg)
83
SLCO1B1*5 g.37041T>C, rs4149056 C__30633906_10
Plasmid Samples
gDNA Samples
![Page 84: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/84.jpg)
84
UGT1A1*6 c.211G>A g.211G>A, rs4148323 C____559715_20
Plasmid Samples
gDNA Samples
![Page 85: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/85.jpg)
85
UGT1A1*60 g. -3279T>G, rs4124874 C___1432134_10
Plasmid Samples
gDNA Samples
![Page 86: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/86.jpg)
86
VKORC1-prom, rs9923231 C__30403261_20
Plasmid Samples
gDNA Samples
![Page 87: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/87.jpg)
87
VKORC1 358C>T P83L, rs7200749 C__29057362_10
Plasmid Samples Cycle 30
gDNA Samples
![Page 88: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/88.jpg)
88
VKORC1 497T>G , rs2884737 C__16147492_20
Plasmid Samples
gDNA Samples
![Page 89: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/89.jpg)
89
VKORC1 1173C>T, rs9934438 C__30204875_10
Plasmid Samples
gDNA Samples
![Page 90: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/90.jpg)
90
VKORC1 3730G>A, rs7294 C___7473918_10
Plasmid Samples
gDNA Samples
![Page 91: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/91.jpg)
91
Apo-ε2 c.526C>T, rs7412 C____904973_10
gDNA Samples
![Page 92: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/92.jpg)
92
Apo-ε4 c.T388C, rs429358 C___3084793_20
gDNA Samples
![Page 93: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/93.jpg)
93
HLA-B*1502 tag rs3745274, rs3909184 C___8692805_10
gDNA Samples
![Page 94: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/94.jpg)
94
HTR2A -1438G>A, rs6311 C___8695278_10
gDNA Samples
![Page 95: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/95.jpg)
95
HTR2C -759C>T, rs3813929 C__27488117_10
gDNA Samples
![Page 96: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/96.jpg)
96
F2 G20210A, rs1799963 C___8726802_20
gDNA Samples
![Page 97: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/97.jpg)
97
Factor V R506Q Leiden mutation, rs6025 C__11975250_10
gDNA Samples
![Page 98: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/98.jpg)
98
F7 rs6042, rs6042 C___3046089_20
gDNA Samples
![Page 99: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/99.jpg)
99
MTHFR C677T Ala222Val, rs1801133 C___1202883_20
gDNA Samples
![Page 100: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/100.jpg)
100
MTHFR A1298C Glu429Ala, rs1801131 C____850486_20
gDNA Samples
![Page 101: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/101.jpg)
101
OPRM1 A118G Asn40Asp, rs1799971 C___8950074_1_
gDNA Samples
![Page 102: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/102.jpg)
102
VKORC1 -1639G>A, rs9923231 C__30403261_20
gDNA Samples
![Page 103: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/103.jpg)
103
VKORC1 1173C>T, rs9934438 C__30204875_10
gDNA Samples
![Page 104: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/104.jpg)
104
VKORC1 3730G>A, rs7294 C___7473918_10
gDNA Samples
![Page 105: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/105.jpg)
105
VKORC1 1542G>C, rs8050894 C___2847860_10
gDNA Samples
![Page 106: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/106.jpg)
106
VKORC1 2255C>T, rs2359612 C__26291751_10
gDNA Samples
![Page 107: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/107.jpg)
107
VKORC1 6009C>T, rs17708472 C__32928084_10
gDNA Samples
![Page 108: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/108.jpg)
108
Gender Assay AMEL_Y-FAM_X-VIC, hCV990000001 C_990000001_10
C_990000001_10, targets a gender-specific polymorphic region in the amelogenin gene. A 6 base deletion occurring in the X-specific AMEL gene is detected by the VIC® dye probe, whereas the FAM™ dye probe detects Y-specific sequences. Male samples run in the heterozygous cluster position and female samples run in the VIC® homozygous cluster.
Note: some males lack the Y-specific amelogenin gene and will type as female. The C_990000001_10 assay should be run in combination with a Y-chromosome assay to identify any mistyped samples (e.g. C___8938211_20; see slide 109).
gDNA Samples
![Page 109: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/109.jpg)
109
Y-chr assay, rs3913290 C___8938211_20
This Y-chromosome-specific assay will amplify only male samples; female samples run with or close to the NTCs.
gDNA Samples
![Page 110: TaqMan® Drug Metabolism Genotyping Assays on ......2014/06/28 · 20 CYP2D6*17 g.1023C>T, rs28371706 C___2222771_A0 – recommended *14 assay version The CYP2D6*17 allele can be](https://reader030.vdocuments.net/reader030/viewer/2022011923/6057ae3dc1d9c4579c28d530/html5/thumbnails/110.jpg)
110
For Research Use Only. Not for use in diagnostic procedures. © 2014 Thermo Fisher Scientific. All rights reserved. All trademarks are the property of Thermo Fisher Scientific and its subsidiaries unless otherwise specified.
Legal notification